ADHD awareness in primary care
| ISRCTN | ISRCTN45400501 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN45400501 |
| IRAS number | 257567 |
| Secondary identifying numbers | IRAS number 257567 |
- Submission date
- 27/08/2019
- Registration date
- 29/08/2019
- Last edited
- 14/12/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Attention Deficit Hyperactive Disorder (ADHD) is a developmental disorder affecting up to 5% of the population. ADHD is underdiagnosed in the UK and the process of accessing care is complex and variable. The care pathway usually involves General practitioners (GPs) referring patients to secondary care for a diagnosis and treatment. It is therefore essential that GPs have a clear understanding of ADHD and associated care pathways in order to provide optimal care for patients. This study aims to evaluate the efficiency and usability of an ADHD online education program for GPs
Who can participate?
GPs and GP trainees from England can participate in this study
What does the study involve?
This study involves GPs taking part in an online education program aimed to increase their awareness and understanding of ADHD. Following a randomised parallel design, the participants will be randomised into two groups, an intervention group and a control group. The intervention group will view the online intervention shortly after consenting to take part in the study while the control group will not view the online program upon taking part but will be invited to view it at a later date. Both groups will complete the same questionnaire on ADHD awareness at three time points, baseline, straight after completion of the intervention/control and 2 weeks after
What are the possible benefits and risks of participating?
Participants will gain a greater understanding of ADHD which in turn will facilitate their practice and help their patients. No risks are anticipated from taking part in this study
Where is the study run from?
The study is run from the University of Nottingham but as this is an online program, it can be accessed from anywhere in the country. All Clinical Research Networks (CRN) in England have agreed to take part, representing a national sample
When is the study starting and how long is it expected to run for?
The recruitment for this study takes place from July 2019 until August 2019. Participants are invited to take part in the study from September 2019
Who is funding the study?
This study is funded by the Economic and Social Research Council (ESRC) as part of a DTC PhD project
Who is the main contact?
The main contact is Blandine French
blandine.french@nottingham.ac.uk
Contact information
Public
Room B15, Yang Fujiya building
Jubilee campus
University of Nottingham
Nottingham
NG8 1BB
United Kingdom
 ORCID ID |
0000-0002-9395-5919 |
|---|---|
| Phone | 0115 823 0261 |
| blandine.french@nottingham.ac.uk |
Scientific
Room B15, Yang Fujiya building
Jubilee campus
University of Nottingham
Nottingham
NG8 1BB
United Kingdom
| ORCID ID |
0000-0002-9395-5919 |
|---|---|
| Phone | 0115 823 0261 |
| blandine.french@nottingham.ac.uk |
Study information
| Study design | Pilot randomised controlled trial with waitlist control |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised parallel trial |
| Study setting(s) | GP practice |
| Study type | Diagnostic |
| Participant information sheet | https://nottingham.onlinesurveys.ac.uk/information-sheet |
| Scientific title | Assessing the effectiveness of an online ADHD awareness online resource in primary care: Pilot of a randomised control trial evaluation |
| Study objectives | The purpose of this study is to explore the efficiency of an online ADHD awareness intervention for GPs. We hypothise that GPs will have a better awareness and understadning of ADHD after taking part in a short online psychoeducation program |
| Ethics approval(s) | 1. Approved 20/02/2019, HRA (Health Research Authority, 3rd Floor Barlow House, Minshull Street, Manchester, M1 3DZ; +44207 104 8193; Hra.approval@nhs.net), ref: IRAS ID 257567 2. Approved 10/04/2019, Faculty of Medicine and Health Science Research Ethics Committee from the University of Nottingham (East Atrium, Jubilee Conference Centre, Jubilee Campus, Nottingham, NG8 1DH; +44115 8467906; sponsor@nottingham.ac.uk), ref: 270-1902, RGS ref: 19002 |
| Health condition(s) or problem(s) studied | Attention Deficit Hyperactivity Disorder (ADHD) |
| Intervention | The participants will be randomly allocated to two groups: intervention or a waitlist control group (no treatment). A simple randomisation process will determine which group each participant is allocated to by generating a random number to create a random allocation sequence. After receiving written consent from the participants, they will be invited to take part in the study. Participants will be advised that the study will last around 60 minutes. After randomisation, participants will be allocated to either the intervention or control group. Both groups will complete the same questionnaire at three time points, baseline, straight after completion of the intervention/control and 2 weeks post-intervention. The intervention group will take part in a 45-minute online psycho-education program on ADHD. The control group will be given a 25-minute video to watch and will be invited to view the intervention after completing the last questionnaire. |
| Intervention type | Mixed |
| Primary outcome measure | ADHD awareness and knowledge measured using a questionnaire (an adapted version of the KADDS (Scuitto et al, 2000) and Adamis et al., 2019) pre and post-intervention |
| Secondary outcome measures | 1. Perceived confidence in the knowledge of ADHD measured using a questionnaire (an adapted version of the KADDS (Scuitto et al, 2000) and Adamis et al., 2019) pre and post-intervention 2. Beliefs and attitudes towards ADHD measured using a questionnaire (an adapted version of the KADDS (Scuitto et al, 2000) and Adamis et al., 2019) pre and post-intervention |
| Overall study start date | 01/09/2018 |
| Completion date | 01/07/2020 |
Eligibility
| Participant type(s) | Health professional |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | 150 |
| Total final enrolment | 235 |
| Key inclusion criteria | 1. Aged 18 or above 2. General practitioners in NHS primary care setting in England, or 3. GP trainees/ registrar in their last 3 years of training |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 10/07/2019 |
| Date of final enrolment | 01/09/2019 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
NG8 1BB
United Kingdom
Sponsor information
University/education
Research and Innovation
East Atrium
Jubilee Conference Centre
Triumph Road
Nottingham
NG8 1DH
England
United Kingdom
| Phone | 01158467103 |
|---|---|
| BB-sponsor@exmail.nottingham.ac.uk | |
| Website | http://www.nottingham.ac.uk/ |
"ROR" |
https://ror.org/01ee9ar58 |
Funders
Funder type
Research council
Government organisation / National government
- Alternative name(s)
- ESRC
- Location
- United Kingdom
Results and Publications
| Intention to publish date | 01/09/2020 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| Publication and dissemination plan | This study is part of a PhD project and will be written up as a chapter of the final PhD thesis. This study will also be published on its own as an academic paper, expected submission by August 2020 |
| IPD sharing plan | The current data sharing plans for this study are unknown and will be available at a later date |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 11/12/2020 | 14/12/2020 | Yes | No |
Editorial Notes
14/12/2020: Publication reference added.
05/03/2020: The intention to publish date was changed from 01/09/2019 to 01/09/2020.
17/01/2020: Internal review.
04/10/2019: The total final enrolment was added.
28/08/2019: Trial’s existence confirmed by Faculty of Medicine and Health Science Research Ethics Committee from the University of Nottingham.
